New Delhi: Amid a shortage of Remdesivir in hospitals all over the country, the Union government has said that 25 new manufacturing sites for the production of the anti-viral drug have been approved and production capacity has now been ramped up to 90 lakh vials per month.

Union chemical and fertilizer minister Mansukh Mandaviya tweeted, ‘Since 12th April, 25 new manufacturing sites for Remdesivir’s production have been approved. Production capacity is now ramped up to >=90 lakhs vials per month. Earlier it was 40 lakhs vials/month.’

He added: ‘Very soon, 3 lakh vials/day will be produced. Monitoring is being done on daily basis. We would not leave any stone unturned to supply Remdesivir.’

Meanwhile, the Home Ministry said the production of life-saving Remdesivir injection used for the treatment of COVID-19 patients and is currently in scarcity in the country, will be augmented to 74 lakh units by next month from 38.80 lakh units now.

The Ministry also asked the States and Union Territories (UTs) to ensure seamless supply and transport of Remdesivir.